Quantitative Proteomics of the Cancer Cell Line Encyclopedia

David P. Nusinow,John Szpyt,Mahmoud Ghandi,Christopher M. Rose,E. Robert McDonald,Marian Kalocsay,Judit Jané-Valbuena,Ellen Gelfand,Devin K. Schweppe,Mark Jedrychowski,Javad Golji,Dale A. Porter,Tomas Rejtar,Y. Karen Wang,Gregory V. Kryukov,Frank Stegmeier,Brian K. Erickson,Levi A. Garraway,William R. Sellers,Steven P. Gygi
DOI: https://doi.org/10.1016/j.cell.2019.12.023
IF: 64.5
2020-01-01
Cell
Abstract:Proteins are essential agents of biological processes. To date, large-scale profiling of cell line collections including the Cancer Cell Line Encyclopedia (CCLE) has focused primarily on genetic information whereas deep interrogation of the proteome has remained out of reach. Here, we expand the CCLE through quantitative profiling of thousands of proteins by mass spectrometry across 375 cell lines from diverse lineages to reveal information undiscovered by DNA and RNA methods. We observe unexpected correlations within and between pathways that are largely absent from RNA. An analysis of microsatellite instable (MSI) cell lines reveals the dysregulation of specific protein complexes associated with surveillance of mutation and translation. These and other protein complexes were associated with sensitivity to knockdown of several different genes. These data in conjunction with the wider CCLE are a broad resource to explore cellular behavior and facilitate cancer research.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is that in cancer research, the existing large - scale cell line data sets (such as the Cancer Cell Line Encyclopedia CCLE) mainly focus on gene - level information, while in - depth proteomic analysis is still insufficient. To bridge this gap, the author conducted an in - depth analysis of the protein expression profiles of 375 cancer cell lines of different lineages through quantitative proteomics techniques, aiming to reveal information at the protein level and explore the associations between this information and genetic characteristics (such as microsatellite instability, individual gene mutations, etc.). Specifically, the objectives of this study include: 1. **Quantitative proteomics analysis**: Obtain high - coverage and high - quality protein expression data through mass spectrometry analysis of 375 cancer cell lines. 2. **Protein expression correlation analysis**: Explore the correlations of protein expression between different pathways and how these correlations differ from RNA expression data. 3. **Impact of microsatellite instability (MSI)**: Study the dysregulation of specific protein complexes in MSI cell lines and understand the impact of high mutation load on the proteome. 4. **Association between protein complexes and gene knockout sensitivity**: Analyze the relationship between the expression of protein complexes and gene knockout sensitivity, providing clues for understanding the functional mechanisms in cancer. Through these analyses, researchers hope to reveal how protein expression patterns are organized and coordinated and how these patterns interact with genetic characteristics, thereby providing new insights for cancer research and treatment. ### Main findings - **Correlation of protein expression**: Unexpected correlations of protein expression between multiple pathways were discovered, and these correlations were not obvious at the RNA level. - **Dysregulation of protein complexes in MSI cell lines**: Multiple protein complexes in MSI cell lines were significantly down - regulated, especially those involved in DNA repair, RNA surveillance, and translation monitoring. - **Association between protein complexes and gene knockout sensitivity**: The expression of certain protein complexes is closely related to gene knockout sensitivity, indicating that these complexes may play a key role in cancer. These findings not only expand the data resources of CCLE but also provide an important reference for understanding proteomic changes in cancer.